The analysis of MMP‐8 and TNF‐α may improve the prediction of FIRS before birth, allowing neonatal risk to be determined earlier, and may impact the management strategy for both women with PPROM and neonates. The gene discussed is TNF; the disease is preterm premature rupture of the membranes.